speb/financial-data huggingface dataset:
IBR.AX income_statement (annual, 2023-06-30) — Net Income Including Noncontrolling Interests: -5491561.00
IBR.AX income_statement (annual, 2023-06-30) — Net Interest Income: 160978.00
IBR.AX cash_flow (annual, 2023-06-30) — Net Investment Purchase And Sale: 148862.00
IBR.AX cash_flow (annual, 2023-06-30) — Net Issuance Payments Of Debt: 1250000.00
IBR.AX cash_flow (annual, 2023-06-30) — Net Long Term Debt Issuance: 1250000.00
IBR.AX income_statement (annual, 2023-06-30) — Net Non Operating Interest Income Expense: 160978.00
IBR.AX balance_sheet (annual, 2023-06-30) — Net PPE: 4554721.00
IBR.AX cash_flow (annual, 2023-06-30) — Net PPE Purchase And Sale: -98657.00
IBR.AX balance_sheet (annual, 2023-06-30) — Net Tangible Assets: 12935134.00
IBR.AX income_statement (annual, 2023-06-30) — Normalized EBITDA: -8184105.00
IBR.AX income_statement (annual, 2023-06-30) — Normalized Income: -5491561.00
IBR.AX income_statement (annual, 2023-06-30) — Operating Income: -8185212.00
IBR.AX balance_sheet (annual, 2023-06-30) — Ordinary Shares Number: 593874927.00
IBR.AX balance_sheet (annual, 2023-06-30) — Other Equity Adjustments: 2610304.00
IBR.AX income_statement (annual, 2023-06-30) — Other Gand A: 132991.00
IBR.AX income_statement (annual, 2023-06-30) — Other Income Expense: 2532673.00
IBR.AX balance_sheet (annual, 2023-06-30) — Other Investments: 53843.00
IBR.AX income_statement (annual, 2023-06-30) — Other Non Operating Income Expenses: 2532673.00
IBR.AX income_statement (annual, 2023-06-30) — Other Operating Expenses: 7036055.00
IBR.AX balance_sheet (annual, 2023-06-30) — Other Payable: 118654.00
IBR.AX balance_sheet (annual, 2023-06-30) — Other Properties: 4539971.00
IBR.AX balance_sheet (annual, 2023-06-30) — Other Receivables: 59513.00
IBR.AX balance_sheet (annual, 2023-06-30) — Other Short Term Investments: 8627778.00
IBR.AX balance_sheet (annual, 2023-06-30) — Payables: 641676.00
IBR.AX balance_sheet (annual, 2023-06-30) — Payables And Accrued Expenses: 641676.00
IBR.AX cash_flow (annual, 2023-06-30) — Paymentsto Suppliersfor Goodsand Services: -1103137.00
IBR.AX balance_sheet (annual, 2023-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 126260.00
IBR.AX balance_sheet (annual, 2023-06-30) — Prepaid Assets: 28763.00
IBR.AX income_statement (annual, 2023-06-30) — Pretax Income: -5491561.00
IBR.AX cash_flow (annual, 2023-06-30) — Purchase Of Investment: -53843.00
IBR.AX cash_flow (annual, 2023-06-30) — Purchase Of PPE: -98657.00
IBR.AX balance_sheet (annual, 2023-06-30) — Receivables: 292383.00
IBR.AX income_statement (annual, 2023-06-30) — Reconciled Depreciation: 1107.00
IBR.AX income_statement (annual, 2023-06-30) — Rent And Landing Fees: 30919.00
IBR.AX cash_flow (annual, 2023-06-30) — Repurchase Of Capital Stock: -81000.00
IBR.AX balance_sheet (annual, 2023-06-30) — Retained Earnings: -248117219.00
IBR.AX income_statement (annual, 2023-06-30) — Salaries And Wages: 984140.00
IBR.AX cash_flow (annual, 2023-06-30) — Sale Of Investment: 202705.00
IBR.AX income_statement (annual, 2023-06-30) — Selling General And Administration: 1148050.00
IBR.AX balance_sheet (annual, 2023-06-30) — Share Issued: 593874927.00
IBR.AX balance_sheet (annual, 2023-06-30) — Stockholders Equity: 12935134.00
IBR.AX balance_sheet (annual, 2023-06-30) — Tangible Book Value: 12935134.00
IBR.AX income_statement (annual, 2023-06-30) — Tax Effect Of Unusual Items: 0.00
IBR.AX income_statement (annual, 2023-06-30) — Tax Provision: 0.00
IBR.AX income_statement (annual, 2023-06-30) — Tax Rate For Calcs: 0.00
IBR.AX cash_flow (annual, 2023-06-30) — Taxes Refund Paid Direct: -952754.00
IBR.AX balance_sheet (annual, 2023-06-30) — Total Assets: 13703070.00
IBR.AX balance_sheet (annual, 2023-06-30) — Total Capitalization: 12935134.00
IBR.AX balance_sheet (annual, 2023-06-30) — Total Equity Gross Minority Interest: 12935134.00
IBR.AX balance_sheet (annual, 2023-06-30) — Total Liabilities Net Minority Interest: 767936.00
IBR.AX balance_sheet (annual, 2023-06-30) — Total Non Current Assets: 4608564.00
IBR.AX balance_sheet (annual, 2023-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
IBR.AX balance_sheet (annual, 2023-06-30) — Working Capital: 8326570.00
IBR.AX income_statement (annual, 2024-06-30) — +Operating Expense: 2272123.00
IBR.AX income_statement (annual, 2024-06-30) — +Total Revenue: 20000.00
IBR.AX balance_sheet (annual, 2024-06-30) — Accounts Payable: 1253793.00
IBR.AX balance_sheet (annual, 2024-06-30) — Accounts Receivable: 30381.00
IBR.AX balance_sheet (annual, 2024-06-30) — Accumulated Depreciation: -1681288.00
IBR.AX income_statement (annual, 2024-06-30) — Basic Average Shares: 600702912.00
IBR.AX income_statement (annual, 2024-06-30) — Basic EPS: -0.01
IBR.AX cash_flow (annual, 2024-06-30) — Beginning Cash Position: 128082.00
IBR.AX cash_flow (annual, 2024-06-30) — Capital Expenditure: -1678569.00
IBR.AX cash_flow (annual, 2024-06-30) — Capital Expenditure Reported: -1622093.00
IBR.AX balance_sheet (annual, 2024-06-30) — Capital Stock: 236425002.00
IBR.AX balance_sheet (annual, 2024-06-30) — Cash And Cash Equivalents: 115524.00
IBR.AX balance_sheet (annual, 2024-06-30) — Cash Cash Equivalents And Short Term Investments: 5401134.00
IBR.AX balance_sheet (annual, 2024-06-30) — Cash Equivalents: 17500.00
IBR.AX balance_sheet (annual, 2024-06-30) — Cash Financial: 98024.00
IBR.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Financing Activities: 1728509.00
IBR.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Investing Activities: -890611.00
IBR.AX cash_flow (annual, 2024-06-30) — Cash Flowsfromusedin Operating Activities Direct: -867956.00
IBR.AX cash_flow (annual, 2024-06-30) — Changes In Cash: -30058.00
IBR.AX cash_flow (annual, 2024-06-30) — Classesof Cash Payments: -869697.00
IBR.AX balance_sheet (annual, 2024-06-30) — Common Stock: 236425002.00
IBR.AX balance_sheet (annual, 2024-06-30) — Common Stock Equity: 8311046.00
IBR.AX cash_flow (annual, 2024-06-30) — Common Stock Issuance: 1340000.00
IBR.AX cash_flow (annual, 2024-06-30) — Common Stock Payments: -52223.00
IBR.AX balance_sheet (annual, 2024-06-30) — Current Assets: 5537659.00
IBR.AX balance_sheet (annual, 2024-06-30) — Current Debt: 2274384.00
IBR.AX balance_sheet (annual, 2024-06-30) — Current Debt And Capital Lease Obligation: 2274384.00
IBR.AX balance_sheet (annual, 2024-06-30) — Current Liabilities: 6075314.00
IBR.AX income_statement (annual, 2024-06-30) — Depreciation Amortization Depletion Income Statement: 1342.00
IBR.AX income_statement (annual, 2024-06-30) — Depreciation And Amortization In Income Statement: 1342.00
IBR.AX income_statement (annual, 2024-06-30) — Depreciation Income Statement: 1342.00
IBR.AX income_statement (annual, 2024-06-30) — Diluted Average Shares: 600702912.00
IBR.AX income_statement (annual, 2024-06-30) — Diluted EPS: -0.01
IBR.AX income_statement (annual, 2024-06-30) — EBIT: -4716144.00
IBR.AX income_statement (annual, 2024-06-30) — EBITDA: -4714802.00
IBR.AX cash_flow (annual, 2024-06-30) — End Cash Position: 98024.00
IBR.AX cash_flow (annual, 2024-06-30) — Financing Cash Flow: 1728509.00
IBR.AX balance_sheet (annual, 2024-06-30) — Foreign Currency Translation Adjustments: 22227356.00
IBR.AX cash_flow (annual, 2024-06-30) — Free Cash Flow: -2546525.00
IBR.AX balance_sheet (annual, 2024-06-30) — Gains Losses Not Affecting Retained Earnings: 25265281.00
IBR.AX income_statement (annual, 2024-06-30) — General And Administrative Expense: 1134769.00
IBR.AX balance_sheet (annual, 2024-06-30) — Gross PPE: 8201763.00
IBR.AX income_statement (annual, 2024-06-30) — Gross Profit: 20000.00
IBR.AX income_statement (annual, 2024-06-30) — Interest Expense: 545874.00
IBR.AX income_statement (annual, 2024-06-30) — Interest Expense Non Operating: 545874.00
IBR.AX income_statement (annual, 2024-06-30) — Interest Income: 1741.00
IBR.AX income_statement (annual, 2024-06-30) — Interest Income Non Operating: 1741.00
IBR.AX cash_flow (annual, 2024-06-30) — Interest Received Direct: 1741.00
IBR.AX balance_sheet (annual, 2024-06-30) — Invested Capital: 10585430.00
IBR.AX cash_flow (annual, 2024-06-30) — Investing Cash Flow: -890611.00
IBR.AX balance_sheet (annual, 2024-06-30) — Investments And Advances: 53843.00
IBR.AX cash_flow (annual, 2024-06-30) — Issuance Of Capital Stock: 1340000.00
IBR.AX cash_flow (annual, 2024-06-30) — Issuance Of Debt: 3630000.00
IBR.AX balance_sheet (annual, 2024-06-30) — Land And Improvements: 75342.00
IBR.AX balance_sheet (annual, 2024-06-30) — Leases: 1464351.00
IBR.AX cash_flow (annual, 2024-06-30) — Long Term Debt Issuance: 3630000.00
IBR.AX cash_flow (annual, 2024-06-30) — Long Term Debt Payments: -1849268.00
IBR.AX balance_sheet (annual, 2024-06-30) — Machinery Furniture Equipment: 160292.00
IBR.AX cash_flow (annual, 2024-06-30) — Net Common Stock Issuance: 1287777.00
IBR.AX balance_sheet (annual, 2024-06-30) — Net Debt: 2158860.00
IBR.AX income_statement (annual, 2024-06-30) — Net Income: -5262018.00
IBR.AX income_statement (annual, 2024-06-30) — Net Income Common Stockholders: -5262018.00
IBR.AX income_statement (annual, 2024-06-30) — Net Income Continuous Operations: -5262018.00
IBR.AX income_statement (annual, 2024-06-30) — Net Income From Continuing And Discontinued Operation: -5262018.00
IBR.AX income_statement (annual, 2024-06-30) — Net Income From Continuing Operation Net Minority Interest: -5262018.00
IBR.AX income_statement (annual, 2024-06-30) — Net Income Including Noncontrolling Interests: -5262018.00
IBR.AX income_statement (annual, 2024-06-30) — Net Interest Income: -544133.00
IBR.AX cash_flow (annual, 2024-06-30) — Net Investment Purchase And Sale: 787958.00
IBR.AX cash_flow (annual, 2024-06-30) — Net Issuance Payments Of Debt: 1780732.00
IBR.AX cash_flow (annual, 2024-06-30) — Net Long Term Debt Issuance: 1780732.00
IBR.AX income_statement (annual, 2024-06-30) — Net Non Operating Interest Income Expense: -544133.00
IBR.AX balance_sheet (annual, 2024-06-30) — Net PPE: 6520475.00
IBR.AX cash_flow (annual, 2024-06-30) — Net PPE Purchase And Sale: -56476.00
IBR.AX balance_sheet (annual, 2024-06-30) — Net Tangible Assets: 8311046.00
IBR.AX income_statement (annual, 2024-06-30) — Normalized EBITDA: -4714802.00
IBR.AX income_statement (annual, 2024-06-30) — Normalized Income: -5262018.00
IBR.AX income_statement (annual, 2024-06-30) — Operating Income: -2252123.00
IBR.AX income_statement (annual, 2024-06-30) — Operating Revenue: 20000.00
IBR.AX balance_sheet (annual, 2024-06-30) — Ordinary Shares Number: 605832069.00
IBR.AX balance_sheet (annual, 2024-06-30) — Other Current Borrowings: 2274384.00
IBR.AX balance_sheet (annual, 2024-06-30) — Other Current Liabilities: 2274384.00
IBR.AX balance_sheet (annual, 2024-06-30) — Other Equity Adjustments: 3037925.00
IBR.AX income_statement (annual, 2024-06-30) — Other Gand A: 169765.00
IBR.AX income_statement (annual, 2024-06-30) — Other Income Expense: -2465762.00
IBR.AX balance_sheet (annual, 2024-06-30) — Other Investments: 53843.00
IBR.AX balance_sheet (annual, 2024-06-30) — Other Non Current Assets: -1.00
IBR.AX income_statement (annual, 2024-06-30) — Other Non Operating Income Expenses: -2465762.00
IBR.AX income_statement (annual, 2024-06-30) — Other Operating Expenses: 979783.00
IBR.AX balance_sheet (annual, 2024-06-30) — Other Payable: 138112.00
IBR.AX balance_sheet (annual, 2024-06-30) — Other Properties: 6501778.00
IBR.AX balance_sheet (annual, 2024-06-30) — Other Receivables: 75022.00
IBR.AX balance_sheet (annual, 2024-06-30) — Other Short Term Investments: 5285610.00
IBR.AX balance_sheet (annual, 2024-06-30) — Payables: 1391905.00
IBR.AX balance_sheet (annual, 2024-06-30) — Payables And Accrued Expenses: 1391905.00
IBR.AX cash_flow (annual, 2024-06-30) — Paymentsto Suppliersfor Goodsand Services: -869697.00
IBR.AX balance_sheet (annual, 2024-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 134641.00
IBR.AX balance_sheet (annual, 2024-06-30) — Prepaid Assets: 31122.00
IBR.AX income_statement (annual, 2024-06-30) — Pretax Income: -5262018.00
IBR.AX income_statement (annual, 2024-06-30) — Provision For Doubtful Accounts: 156229.00
IBR.AX cash_flow (annual, 2024-06-30) — Purchase Of PPE: -56476.00
IBR.AX balance_sheet (annual, 2024-06-30) — Receivables: 105403.00
IBR.AX income_statement (annual, 2024-06-30) — Reconciled Depreciation: 1342.00
IBR.AX income_statement (annual, 2024-06-30) — Rent And Landing Fees: 26050.00
IBR.AX cash_flow (annual, 2024-06-30) — Repayment Of Debt: -1849268.00
IBR.AX cash_flow (annual, 2024-06-30) — Repurchase Of Capital Stock: -52223.00
IBR.AX balance_sheet (annual, 2024-06-30) — Retained Earnings: -253379237.00
IBR.AX income_statement (annual, 2024-06-30) — Salaries And Wages: 938954.00
IBR.AX cash_flow (annual, 2024-06-30) — Sale Of Investment: 787958.00
IBR.AX income_statement (annual, 2024-06-30) — Selling General And Administration: 1134769.00
IBR.AX balance_sheet (annual, 2024-06-30) — Share Issued: 605832069.00
IBR.AX balance_sheet (annual, 2024-06-30) — Stockholders Equity: 8311046.00
IBR.AX balance_sheet (annual, 2024-06-30) — Tangible Book Value: 8311046.00
IBR.AX income_statement (annual, 2024-06-30) — Tax Effect Of Unusual Items: 0.00
IBR.AX income_statement (annual, 2024-06-30) — Tax Provision: 0.00
IBR.AX income_statement (annual, 2024-06-30) — Tax Rate For Calcs: 0.00
IBR.AX balance_sheet (annual, 2024-06-30) — Total Assets: 12111976.00
IBR.AX balance_sheet (annual, 2024-06-30) — Total Capitalization: 8311046.00
IBR.AX balance_sheet (annual, 2024-06-30) — Total Debt: 2274384.00
IBR.AX balance_sheet (annual, 2024-06-30) — Total Equity Gross Minority Interest: 8311046.00
IBR.AX balance_sheet (annual, 2024-06-30) — Total Liabilities Net Minority Interest: 6075314.00
IBR.AX balance_sheet (annual, 2024-06-30) — Total Non Current Assets: 6574317.00
IBR.AX balance_sheet (annual, 2024-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
IBR.AX balance_sheet (annual, 2024-06-30) — Working Capital: -537655.00
IBRX balance_sheet (annual, 2021-12-31) — Available For Sale Securities: 822000.00
IBRX balance_sheet (annual, 2021-12-31) — Buildings And Improvements: 0.00
IBRX cash_flow (annual, 2021-12-31) — Common Stock Payments: 0.00
IBRX balance_sheet (annual, 2021-12-31) — Current Debt: 299236000.00
IBRX balance_sheet (annual, 2021-12-31) — Current Notes Payable: 299236000.00
IBRX cash_flow (annual, 2021-12-31) — Deferred Income Tax: -8000.00
IBRX cash_flow (annual, 2021-12-31) — Deferred Tax: -8000.00
IBRX cash_flow (annual, 2021-12-31) — Earnings Losses From Equity Investments: 803000.00
IBRX balance_sheet (annual, 2021-12-31) — Investmentin Financial Assets: 822000.00
IBRX balance_sheet (annual, 2021-12-31) — Investments And Advances: 7597000.00
IBRX balance_sheet (annual, 2021-12-31) — Long Term Equity Investment: 822000.00
IBRX cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 0.00
IBRX balance_sheet (annual, 2021-12-31) — Non Current Deferred Liabilities: 162000.00
IBRX balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Liabilities: 162000.00
IBRX balance_sheet (annual, 2021-12-31) — Other Current Borrowings: 299236000.00
IBRX balance_sheet (annual, 2021-12-31) — Other Investments: 6775000.00
IBRX cash_flow (annual, 2021-12-31) — Purchase Of Business: 0.00
IBRX cash_flow (annual, 2021-12-31) — Repurchase Of Capital Stock: 0.00
IBRX cash_flow (annual, 2021-12-31) — Sale Of PPE: 20498000.00
IBRX income_statement (annual, 2021-12-31) — Securities Amortization: 488000.00
IBRX income_statement (annual, 2022-12-31) — +Operating Expense: 350857000.00
IBRX income_statement (annual, 2022-12-31) — +Total Revenue: 240000.00
IBRX balance_sheet (annual, 2022-12-31) — Accounts Payable: 21016000.00
IBRX balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -69252000.00
IBRX balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 1930936000.00
IBRX cash_flow (annual, 2022-12-31) — Amortization Of Securities: 1318000.00
IBRX cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 2014000.00
IBRX balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 840000.00
IBRX income_statement (annual, 2022-12-31) — Basic Average Shares: 399900000.00
IBRX income_statement (annual, 2022-12-31) — Basic EPS: -1.04
IBRX cash_flow (annual, 2022-12-31) — Beginning Cash Position: 181280000.00
IBRX cash_flow (annual, 2022-12-31) — Capital Expenditure: -99391000.00
IBRX balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 50601000.00
IBRX balance_sheet (annual, 2022-12-31) — Capital Stock: 42000.00
IBRX balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 104641000.00
IBRX balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 107184000.00
IBRX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 233613000.00
IBRX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 27297000.00
IBRX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -337509000.00
IBRX cash_flow (annual, 2022-12-31) — Change In Account Payable: 8000000.00
IBRX cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 4102000.00
IBRX cash_flow (annual, 2022-12-31) — Change In Inventory: 0.00
IBRX cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 1998000.00
IBRX cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -4319000.00
IBRX cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -1225000.00
IBRX cash_flow (annual, 2022-12-31) — Change In Payable: 8000000.00
IBRX cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 12102000.00
IBRX cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -16557000.00
IBRX cash_flow (annual, 2022-12-31) — Change In Receivables: 0.00
IBRX cash_flow (annual, 2022-12-31) — Change In Working Capital: -8001000.00
IBRX cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 0.00
IBRX cash_flow (annual, 2022-12-31) — Changes In Cash: -76599000.00
IBRX balance_sheet (annual, 2022-12-31) — Common Stock: 42000.00
IBRX balance_sheet (annual, 2022-12-31) — Common Stock Equity: -447327000.00
IBRX cash_flow (annual, 2022-12-31) — Common Stock Issuance: 60427000.00
IBRX balance_sheet (annual, 2022-12-31) — Construction In Progress: 72693000.00
IBRX income_statement (annual, 2022-12-31) — Cost Of Revenue: 0.00
IBRX balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 22089000.00
IBRX balance_sheet (annual, 2022-12-31) — Current Assets: 140577000.00
IBRX balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 2650000.00
IBRX balance_sheet (annual, 2022-12-31) — Current Debt: 431901000.00
IBRX balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 434551000.00
IBRX balance_sheet (annual, 2022-12-31) — Current Liabilities: 500861000.00
IBRX cash_flow (annual, 2022-12-31) — Deferred Income Tax: -4000.00
IBRX cash_flow (annual, 2022-12-31) — Deferred Tax: -4000.00
IBRX cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 18260000.00
IBRX cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 18260000.00
IBRX balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 21636000.00
IBRX income_statement (annual, 2022-12-31) — Diluted Average Shares: 399900000.00
IBRX income_statement (annual, 2022-12-31) — Diluted EPS: -1.04
IBRX income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -416567000.00
IBRX balance_sheet (annual, 2022-12-31) — Duefrom Related Parties Current: 1890000.00
IBRX balance_sheet (annual, 2022-12-31) — Dueto Related Parties Current: 3469000.00
IBRX income_statement (annual, 2022-12-31) — EBIT: -370141000.00
IBRX income_statement (annual, 2022-12-31) — EBITDA: -351881000.00
IBRX income_statement (annual, 2022-12-31) — Earnings From Equity Interest: -12107000.00
IBRX cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 284000.00
IBRX cash_flow (annual, 2022-12-31) — End Cash Position: 104965000.00
IBRX cash_flow (annual, 2022-12-31) — Financing Cash Flow: 233613000.00
IBRX cash_flow (annual, 2022-12-31) — Free Cash Flow: -436900000.00
IBRX cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -13460000.00
IBRX income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 7662000.00
IBRX balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 183000.00
IBRX balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 20003000.00
IBRX balance_sheet (annual, 2022-12-31) — Gross PPE: 258699000.00
IBRX income_statement (annual, 2022-12-31) — Gross Profit: 240000.00
IBRX income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 681000.00
IBRX cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 2000.00
IBRX income_statement (annual, 2022-12-31) — Interest Expense: 47145000.00
IBRX income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 47145000.00
IBRX income_statement (annual, 2022-12-31) — Interest Income: 2708000.00
IBRX income_statement (annual, 2022-12-31) — Interest Income Non Operating: 2708000.00
IBRX cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 35442000.00
IBRX balance_sheet (annual, 2022-12-31) — Invested Capital: 225845000.00
IBRX cash_flow (annual, 2022-12-31) — Investing Cash Flow: 27297000.00
IBRX balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 840000.00
IBRX balance_sheet (annual, 2022-12-31) — Investments And Advances: 840000.00
IBRX cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 60427000.00
IBRX cash_flow (annual, 2022-12-31) — Issuance Of Debt: 174125000.00
IBRX balance_sheet (annual, 2022-12-31) — Leases: 68710000.00
IBRX balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 47951000.00
IBRX balance_sheet (annual, 2022-12-31) — Long Term Debt: 241271000.00
IBRX balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 289222000.00
IBRX cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 174125000.00
IBRX cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -58000.00
IBRX balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 840000.00
IBRX balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 3563000.00
IBRX balance_sheet (annual, 2022-12-31) — Minority Interest: -2493000.00
IBRX income_statement (annual, 2022-12-31) — Minority Interests: 753000.00
IBRX cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -1000000.00
IBRX cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 60427000.00
IBRX balance_sheet (annual, 2022-12-31) — Net Debt: 568531000.00
IBRX income_statement (annual, 2022-12-31) — Net Income: -416567000.00
IBRX income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -416567000.00
IBRX income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -417320000.00
IBRX income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -416567000.00
IBRX income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -416567000.00
IBRX cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -417320000.00
IBRX income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -417320000.00
IBRX cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -21229000.00
IBRX income_statement (annual, 2022-12-31) — Net Interest Income: -60807000.00
IBRX cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 127688000.00
IBRX cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 174067000.00
IBRX cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 174067000.00
IBRX income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -60807000.00
IBRX cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -339000.00
IBRX balance_sheet (annual, 2022-12-31) — Net PPE: 189447000.00
IBRX cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -78162000.00
IBRX cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 174125000.00
IBRX balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -467330000.00
IBRX balance_sheet (annual, 2022-12-31) — Non Current Note Receivables: 6629000.00
IBRX income_statement (annual, 2022-12-31) — Normalized EBITDA: -358862000.00
IBRX income_statement (annual, 2022-12-31) — Normalized Income: -422081990.00
IBRX cash_flow (annual, 2022-12-31) — Operating Cash Flow: -337509000.00
IBRX cash_flow (annual, 2022-12-31) — Operating Gains Losses: -13460000.00
IBRX income_statement (annual, 2022-12-31) — Operating Income: -350617000.00
IBRX income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
IBRX balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 421569115.00
IBRX balance_sheet (annual, 2022-12-31) — Other Current Assets: 2899000.00
IBRX balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 431901000.00
IBRX balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 1628000.00
IBRX balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 183000.00
IBRX income_statement (annual, 2022-12-31) — Other Income Expense: -5862000.00
IBRX balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 20003000.00
IBRX balance_sheet (annual, 2022-12-31) — Other Investments: 4860000.00
IBRX cash_flow (annual, 2022-12-31) — Other Non Cash Items: 35311000.00
IBRX balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 4860000.00
IBRX balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 457000.00
IBRX income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -736000.00
IBRX balance_sheet (annual, 2022-12-31) — Other Properties: 113733000.00
IBRX balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 2543000.00
IBRX balance_sheet (annual, 2022-12-31) — Payables: 24485000.00
IBRX balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 46574000.00
IBRX balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 18108000.00
IBRX balance_sheet (annual, 2022-12-31) — Prepaid Assets: 28604000.00
IBRX income_statement (annual, 2022-12-31) — Pretax Income: -417286000.00
IBRX cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: -542000.00
IBRX balance_sheet (annual, 2022-12-31) — Properties: 0.00
IBRX cash_flow (annual, 2022-12-31) — Purchase Of Business: -1000000.00
IBRX cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -21229000.00
IBRX cash_flow (annual, 2022-12-31) — Purchase Of Investment: -34312000.00
IBRX cash_flow (annual, 2022-12-31) — Purchase Of PPE: -78162000.00
IBRX balance_sheet (annual, 2022-12-31) — Receivables: 1890000.00
IBRX income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 0.00
IBRX income_statement (annual, 2022-12-31) — Reconciled Depreciation: 18260000.00
IBRX cash_flow (annual, 2022-12-31) — Repayment Of Debt: -58000.00
IBRX income_statement (annual, 2022-12-31) — Research And Development: 248149000.00
IBRX balance_sheet (annual, 2022-12-31) — Retained Earnings: -2378488000.00
IBRX cash_flow (annual, 2022-12-31) — Sale Of Investment: 162000000.00
IBRX cash_flow (annual, 2022-12-31) — Sale Of PPE: 0.00
IBRX income_statement (annual, 2022-12-31) — Securities Amortization: 1486000.00
IBRX income_statement (annual, 2022-12-31) — Selling General And Administration: 102708000.00
IBRX balance_sheet (annual, 2022-12-31) — Share Issued: 421732915.00
IBRX cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 174125000.00
IBRX income_statement (annual, 2022-12-31) — Special Income Charges: -681000.00
IBRX cash_flow (annual, 2022-12-31) — Stock Based Compensation: 40179000.00
IBRX balance_sheet (annual, 2022-12-31) — Stockholders Equity: -447327000.00
IBRX balance_sheet (annual, 2022-12-31) — Tangible Book Value: -467330000.00
IBRX income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 1466010.00
IBRX income_statement (annual, 2022-12-31) — Tax Provision: 34000.00
IBRX income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
IBRX balance_sheet (annual, 2022-12-31) — Total Assets: 362356000.00
IBRX balance_sheet (annual, 2022-12-31) — Total Capitalization: -206056000.00
IBRX balance_sheet (annual, 2022-12-31) — Total Debt: 723773000.00
IBRX balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: -449820000.00
IBRX income_statement (annual, 2022-12-31) — Total Expenses: 350857000.00
IBRX balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 812176000.00
IBRX balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 221779000.00
IBRX balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 311315000.00
IBRX income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -351298000.00
IBRX income_statement (annual, 2022-12-31) — Total Other Finance Cost: 16370000.00
IBRX income_statement (annual, 2022-12-31) — Total Unusual Items: 6981000.00
IBRX income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 6981000.00
IBRX balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 163800.00
IBRX cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 4190000.00
IBRX balance_sheet (annual, 2022-12-31) — Working Capital: -360284000.00
IBRX income_statement (annual, 2023-12-31) — +Operating Expense: 361986000.00
IBRX income_statement (annual, 2023-12-31) — +Total Revenue: 622000.00
IBRX balance_sheet (annual, 2023-12-31) — Accounts Payable: 9195000.00
IBRX balance_sheet (annual, 2023-12-31) — Accounts Receivable: 0.00
IBRX balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -84376000.00
IBRX balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 2374620000.00
IBRX cash_flow (annual, 2023-12-31) — Amortization Of Securities: -137000.00
IBRX cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 886000.00
IBRX balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 891000.00
IBRX income_statement (annual, 2023-12-31) — Basic Average Shares: 508636000.00
IBRX income_statement (annual, 2023-12-31) — Basic EPS: -1.15
IBRX cash_flow (annual, 2023-12-31) — Beginning Cash Position: 104965000.00
IBRX cash_flow (annual, 2023-12-31) — Capital Expenditure: -30584000.00
IBRX balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 45186000.00
IBRX balance_sheet (annual, 2023-12-31) — Capital Stock: 67000.00
IBRX balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 265453000.00
IBRX balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 266462000.00
IBRX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 558341000.00
IBRX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -30470000.00
IBRX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -366757000.00
IBRX cash_flow (annual, 2023-12-31) — Change In Account Payable: -6476000.00
IBRX cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 6689000.00
IBRX cash_flow (annual, 2023-12-31) — Change In Inventory: 0.00
IBRX cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 1764000.00
IBRX cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -2978000.00
IBRX cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -1129000.00
IBRX cash_flow (annual, 2023-12-31) — Change In Payable: -6476000.00
IBRX cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 213000.00
IBRX cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 5958000.00
IBRX cash_flow (annual, 2023-12-31) — Change In Receivables: 0.00
IBRX cash_flow (annual, 2023-12-31) — Change In Working Capital: 3828000.00
IBRX cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 0.00
IBRX cash_flow (annual, 2023-12-31) — Changes In Cash: 161114000.00
IBRX balance_sheet (annual, 2023-12-31) — Common Stock: 67000.00
IBRX balance_sheet (annual, 2023-12-31) — Common Stock Equity: -586987000.00
IBRX cash_flow (annual, 2023-12-31) — Common Stock Issuance: 100561000.00
IBRX balance_sheet (annual, 2023-12-31) — Construction In Progress: 84436000.00
IBRX income_statement (annual, 2023-12-31) — Cost Of Revenue: 0.00
IBRX balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 24401000.00
IBRX balance_sheet (annual, 2023-12-31) — Current Assets: 294084000.00
IBRX balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 5244000.00
IBRX balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 5244000.00
IBRX balance_sheet (annual, 2023-12-31) — Current Liabilities: 58283000.00
IBRX cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 18512000.00
IBRX cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 18512000.00
IBRX balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 154103000.00
IBRX income_statement (annual, 2023-12-31) — Diluted Average Shares: 508636000.00
IBRX income_statement (annual, 2023-12-31) — Diluted EPS: -1.15
IBRX income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -583196000.00
IBRX balance_sheet (annual, 2023-12-31) — Duefrom Related Parties Current: 2019000.00
IBRX balance_sheet (annual, 2023-12-31) — Dueto Related Parties Current: 1136000.00
IBRX income_statement (annual, 2023-12-31) — EBIT: -497089000.00
IBRX income_statement (annual, 2023-12-31) — EBITDA: -478577000.00
IBRX income_statement (annual, 2023-12-31) — Earnings From Equity Interest: -7549000.00
IBRX cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -292000.00
IBRX cash_flow (annual, 2023-12-31) — End Cash Position: 265787000.00
IBRX cash_flow (annual, 2023-12-31) — Financing Cash Flow: 558341000.00
IBRX balance_sheet (annual, 2023-12-31) — Finished Goods: 0.00
IBRX cash_flow (annual, 2023-12-31) — Free Cash Flow: -397341000.00
IBRX cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 49610000.00
IBRX income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -47332000.00
IBRX balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 10000.00
IBRX balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 17093000.00
IBRX balance_sheet (annual, 2023-12-31) — Gross PPE: 267001000.00
IBRX income_statement (annual, 2023-12-31) — Gross Profit: 622000.00
IBRX income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 886000.00
IBRX cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 8000.00
IBRX income_statement (annual, 2023-12-31) — Interest Expense: 86803000.00
IBRX income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 86803000.00
IBRX income_statement (annual, 2023-12-31) — Interest Income: 863000.00
IBRX income_statement (annual, 2023-12-31) — Interest Income Non Operating: 863000.00
IBRX cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 77192000.00
IBRX balance_sheet (annual, 2023-12-31) — Inventory: 0.00
IBRX balance_sheet (annual, 2023-12-31) — Invested Capital: 94550000.00
IBRX cash_flow (annual, 2023-12-31) — Investing Cash Flow: -30470000.00
IBRX balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 891000.00
IBRX balance_sheet (annual, 2023-12-31) — Investments And Advances: 891000.00
IBRX cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 100561000.00
IBRX cash_flow (annual, 2023-12-31) — Issuance Of Debt: 258700000.00
IBRX balance_sheet (annual, 2023-12-31) — Leases: 72552000.00
IBRX balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 39942000.00
IBRX balance_sheet (annual, 2023-12-31) — Long Term Debt: 681537000.00
IBRX balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 721479000.00
IBRX cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 258700000.00
IBRX cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -77000.00
IBRX balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 3555000.00
IBRX balance_sheet (annual, 2023-12-31) — Minority Interest: 1050000.00
IBRX income_statement (annual, 2023-12-31) — Minority Interests: 656000.00
IBRX cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
IBRX cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 100561000.00
IBRX balance_sheet (annual, 2023-12-31) — Net Debt: 416084000.00
IBRX income_statement (annual, 2023-12-31) — Net Income: -583196000.00
IBRX income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -583196000.00
IBRX income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -583852000.00
IBRX income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -583196000.00
IBRX income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -583196000.00
IBRX cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -583852000.00
IBRX income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -583852000.00
IBRX cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: 0.00
IBRX income_statement (annual, 2023-12-31) — Net Interest Income: -128336000.00
IBRX cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 114000.00
IBRX cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 258623000.00
IBRX cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 258623000.00
IBRX income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -128336000.00
IBRX cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 192764000.00
IBRX balance_sheet (annual, 2023-12-31) — Net PPE: 182625000.00
IBRX cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -30584000.00
IBRX cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 0.00
IBRX balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -604080000.00
IBRX balance_sheet (annual, 2023-12-31) — Non Current Note Receivables: 6879000.00
IBRX income_statement (annual, 2023-12-31) — Normalized EBITDA: -430359000.00
IBRX income_statement (annual, 2023-12-31) — Normalized Income: -534981303.21
IBRX cash_flow (annual, 2023-12-31) — Operating Cash Flow: -366757000.00
IBRX cash_flow (annual, 2023-12-31) — Operating Gains Losses: 49610000.00
IBRX income_statement (annual, 2023-12-31) — Operating Income: -361364000.00
IBRX income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
IBRX balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 670867344.00
IBRX balance_sheet (annual, 2023-12-31) — Other Current Assets: 2625000.00
IBRX balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 716000.00
IBRX balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 10000.00
IBRX income_statement (annual, 2023-12-31) — Other Income Expense: -94193000.00
IBRX balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 17093000.00
IBRX cash_flow (annual, 2023-12-31) — Other Non Cash Items: 93642000.00
IBRX balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 2880000.00
IBRX balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 156524000.00
IBRX income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -38426000.00
IBRX balance_sheet (annual, 2023-12-31) — Other Properties: 106458000.00
IBRX balance_sheet (annual, 2023-12-31) — Other Receivables: 1149000.00
IBRX balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 1009000.00
IBRX balance_sheet (annual, 2023-12-31) — Payables: 10331000.00
IBRX balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 34732000.00
IBRX balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 17591000.00
IBRX balance_sheet (annual, 2023-12-31) — Prepaid Assets: 21829000.00
IBRX income_statement (annual, 2023-12-31) — Pretax Income: -583892000.00
IBRX cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 6393000.00
IBRX balance_sheet (annual, 2023-12-31) — Properties: 0.00
IBRX cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
IBRX cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: 0.00
IBRX cash_flow (annual, 2023-12-31) — Purchase Of Investment: -10358000.00
IBRX cash_flow (annual, 2023-12-31) — Purchase Of PPE: -30584000.00
IBRX balance_sheet (annual, 2023-12-31) — Raw Materials: 0.00
IBRX balance_sheet (annual, 2023-12-31) — Receivables: 3168000.00
IBRX income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 0.00
IBRX income_statement (annual, 2023-12-31) — Reconciled Depreciation: 18512000.00
IBRX cash_flow (annual, 2023-12-31) — Repayment Of Debt: -77000.00
IBRX income_statement (annual, 2023-12-31) — Research And Development: 232366000.00
IBRX balance_sheet (annual, 2023-12-31) — Retained Earnings: -2961684000.00
IBRX cash_flow (annual, 2023-12-31) — Sale Of Investment: 10472000.00
IBRX cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
IBRX income_statement (annual, 2023-12-31) — Securities Amortization: -1844000.00
IBRX income_statement (annual, 2023-12-31) — Selling General And Administration: 129620000.00
IBRX balance_sheet (annual, 2023-12-31) — Share Issued: 671031144.00
IBRX cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 0.00
IBRX income_statement (annual, 2023-12-31) — Special Income Charges: -886000.00
IBRX cash_flow (annual, 2023-12-31) — Stock Based Compensation: 49163000.00
IBRX balance_sheet (annual, 2023-12-31) — Stockholders Equity: -586987000.00
IBRX balance_sheet (annual, 2023-12-31) — Tangible Book Value: -604080000.00
IBRX income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -3303.21
IBRX income_statement (annual, 2023-12-31) — Tax Provision: -40000.00
IBRX income_statement (annual, 2023-12-31) — Tax Rate For Calcs:
IBRX balance_sheet (annual, 2023-12-31) — Total Assets: 504452000.00
IBRX balance_sheet (annual, 2023-12-31) — Total Capitalization: 94550000.00
IBRX balance_sheet (annual, 2023-12-31) — Total Debt: 726723000.00
IBRX balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -585937000.00
IBRX income_statement (annual, 2023-12-31) — Total Expenses: 361986000.00
IBRX balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 1090389000.00
IBRX balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 210368000.00
IBRX balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 1032106000.00
IBRX income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -362250000.00
IBRX income_statement (annual, 2023-12-31) — Total Other Finance Cost: 42396000.00
IBRX income_statement (annual, 2023-12-31) — Total Unusual Items: -48218000.00
IBRX income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -48218000.00
IBRX balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 163800.00
IBRX cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: 1591000.00
IBRX balance_sheet (annual, 2023-12-31) — Work In Process: 0.00
IBRX balance_sheet (annual, 2023-12-31) — Working Capital: 235801000.00
IBRX income_statement (quarterly, 2024-09-30) — Average Dilution Earnings: -14505000.00
IBRX income_statement (quarterly, 2024-09-30) — Earnings From Equity Interest: 0.00
IBRX balance_sheet (quarterly, 2024-09-30) — Finished Goods: 0.00
IBRX balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 0.00
IBRX balance_sheet (quarterly, 2024-09-30) — Investments And Advances: 0.00
IBRX cash_flow (quarterly, 2024-09-30) — Issuance Of Debt: 0.00
IBRX cash_flow (quarterly, 2024-09-30) — Long Term Debt Issuance: 0.00
IBRX cash_flow (quarterly, 2024-09-30) — Net Other Financing Charges: 0.00
IBRX balance_sheet (quarterly, 2024-09-30) — Raw Materials: 0.00
IBRX cash_flow (quarterly, 2024-09-30) — Unrealized Gain Loss On Investment Securities: 505000.00
IBRX balance_sheet (quarterly, 2024-09-30) — Work In Process: 1958000.00
IBRX income_statement (annual, 2024-12-31) — +Operating Expense: 358927000.00
IBRX income_statement (annual, 2024-12-31) — +Total Revenue: 14745000.00
IBRX balance_sheet (annual, 2024-12-31) — Accounts Payable: 6725000.00
IBRX balance_sheet (annual, 2024-12-31) — Accounts Receivable: 2360000.00
IBRX balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -99589000.00
IBRX balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 2884867000.00
IBRX cash_flow (annual, 2024-12-31) — Amortization Of Securities: -1489000.00
IBRX cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
IBRX income_statement (annual, 2024-12-31) — Basic Average Shares: 697312000.00
IBRX income_statement (annual, 2024-12-31) — Basic EPS: -0.59
IBRX cash_flow (annual, 2024-12-31) — Beginning Cash Position: 265787000.00
IBRX cash_flow (annual, 2024-12-31) — Capital Expenditure: -6888000.00
IBRX balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 42289000.00
IBRX balance_sheet (annual, 2024-12-31) — Capital Stock: 85000.00
IBRX balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 143428000.00
IBRX balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 149809000.00
IBRX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 281630000.00
IBRX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -12246000.00
IBRX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -391236000.00
IBRX cash_flow (annual, 2024-12-31) — Change In Account Payable: -3167000.00
IBRX cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -1508000.00
IBRX cash_flow (annual, 2024-12-31) — Change In Inventory: -8272000.00
IBRX cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -1108000.00
IBRX cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -5473000.00
IBRX cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 763000.00
IBRX cash_flow (annual, 2024-12-31) — Change In Payable: -3167000.00
IBRX cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -4675000.00
IBRX cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 1703000.00
IBRX cash_flow (annual, 2024-12-31) — Change In Receivables: -2360000.00
IBRX cash_flow (annual, 2024-12-31) — Change In Working Capital: -19422000.00
IBRX cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -2360000.00
IBRX cash_flow (annual, 2024-12-31) — Changes In Cash: -121852000.00
IBRX balance_sheet (annual, 2024-12-31) — Common Stock: 85000.00
IBRX balance_sheet (annual, 2024-12-31) — Common Stock Equity: -489098000.00
IBRX cash_flow (annual, 2024-12-31) — Common Stock Issuance: 111357000.00
IBRX balance_sheet (annual, 2024-12-31) — Construction In Progress: 86417000.00
IBRX income_statement (annual, 2024-12-31) — Cost Of Revenue: 0.00
IBRX balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 24505000.00
IBRX balance_sheet (annual, 2024-12-31) — Current Assets: 184586000.00
IBRX balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 7466000.00
IBRX balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 7466000.00
IBRX balance_sheet (annual, 2024-12-31) — Current Liabilities: 54944000.00
IBRX cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 17554000.00
IBRX cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 17554000.00
IBRX balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 34695000.00
IBRX income_statement (annual, 2024-12-31) — Diluted Average Shares: 700443000.00
IBRX income_statement (annual, 2024-12-31) — Diluted EPS: -0.62
IBRX income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -413564000.00
IBRX balance_sheet (annual, 2024-12-31) — Duefrom Related Parties Current: 293000.00
IBRX balance_sheet (annual, 2024-12-31) — Dueto Related Parties Current: 173000.00
IBRX income_statement (annual, 2024-12-31) — EBIT: -281905000.00
IBRX income_statement (annual, 2024-12-31) — EBITDA: -264351000.00
IBRX income_statement (annual, 2024-12-31) — Earnings From Equity Interest: 0.00
IBRX income_statement (quarterly, 2024-12-31) — Earnings From Equity Interest: 0.00
IBRX cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -23000.00
IBRX cash_flow (annual, 2024-12-31) — End Cash Position: 143912000.00
IBRX cash_flow (annual, 2024-12-31) — Financing Cash Flow: 281630000.00
IBRX balance_sheet (annual, 2024-12-31) — Finished Goods: 767000.00
IBRX balance_sheet (quarterly, 2024-12-31) — Finished Goods: 767000.00
IBRX cash_flow (annual, 2024-12-31) — Free Cash Flow: -398124000.00
IBRX cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -33432000.00